you'll feel a quick pinch and that's it
Research suggested that this lipolysis peptide may potentially facilitate the release of fat from adipose tissue while moderating the accumulation of new fat deposits in laboratory models, without appearing to alter caloric intake or appetite or adversely affect insulin sensitivity in these experimental settings
Before using AOD-9604 Peptide Vials for clinical studies, you must reconstitute the peptide with sterile or bacteriostatic water, discover the full range of lab consumables
You take certain medications: Long-term use of proton pump inhibitors (for acid reflux) or metformin (for diabetes) can interfere with B12 absorption
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL reconstitution) Concentration after reconstitution: 2.0 mg/mL AOD-9604 | 1.0 mg/mL CJC-1295 | 1.0 mg/mL Ipamorelin Frequency: Inject once daily subcutaneously, preferably in the morning or before bed on an empty stomach
AOD 9604 Peptide Therapy Dosing Chart Disclaimer Confidential Optimization